Potential therapeutic effects related to Covid-19
Last updated 2022-Mar-31
CDC treatment guidelines are located here
https://www.covid19treatmentguidelines.nih.gov/about-the-guidelines/whats-new/
Clinical trials are recommended for products which are Interleukin-1 Inhibitors or Tyrosine Kinase Inhibitors
Research shows that nerolidol inhibits Interleukin-1β in vitro and in vivo:
-
Nerolidol inhibits the LOX-1 / IL-1β signaling
https://pubmed.ncbi.nlm.nih.gov/31926445/
"The administration of nerolidol reduced the severity of fungal keratitis with infiltration of fewer inflammatory cells and reduced levels of the LOX-1, as well the anti-inflammatory cytokines such as IL-1β"
-
Nerolidol Protects Against LPS-induced Acute Kidney Injury via Inhibiting TLR4/NF-κB Signaling- https://pubmed.ncbi.nlm.nih.gov/28093813/
"Nerolidol notably inhibited the increase of TNFα and IL-1β"
-
Nerolidol exhibits antinociceptive and anti-inflammatory activity: involvement of the GABAergic system and proinflammatory cytokines
https://pubmed.ncbi.nlm.nih.gov/26791997/
"Nerolidol reduced production of interleukin 1 beta (IL-1β) in LPS-stimulated, peritoneal macrophages."
-
Effect of nerolidol on cyclophosphamide-induced bone marrow and hematologic toxicity in Swiss albino mice
https://pubmed.ncbi.nlm.nih.gov/31987924/
"biochemical analysis revealed increased malondialdehyde (MDA), tumor necrosis factor α (TNF-α), interleukin (IL)-6, and IL-1β levels and reduced superoxide dismutase (SOD), catalase (CAT), and IL-10 levels (from cyclophosphamide). Treatment with NER significantly reversed the hematotoxic and myelotoxic aberrations ( and retained the structural integrity of bone marrow."
Computer models indicate nerolidol has very good potential to inhibit Tyrosine Kinase:
-
Tyrosinase inhibitory activity, molecular docking studies and antioxidant potential of chemotypes of Lippia origanoides (Verbenaceae) essential oils
https://pubmed.ncbi.nlm.nih.gov/28459864/
"The best docking energies were observed with thymol and (E)-nerolidol (-79.8 kcal.mol-1), which suggested H-bonding interactions with Met281 and His263 (thymol) and His259, His263 ((E)-nerolidol)."
Devil's club essential oil (branch bark) contains more than 50% nerolidol and based upon published studies and CDC treatment guidelines is eligible to be a candidate for clinical trials for treatment of Covid-19.
Additional studies:
-
Suppresses inflammation during lung injuries (in mice)
Nerolidol Suppresses the Inflammatory Response during Lipopolysaccharide-Induced Acute Lung Injury via the Modulation of Antioxidant Enzymes and the AMPK/Nrf-2/HO-1 Pathway
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885193/
-
Antiviral agents in essential oils to treat SARS-CoV-2 (computer projection)
Essential Oils as Antiviral Agents. Potential of Essential Oils to Treat SARS-CoV-2 Infection: An In-Silico Investigation
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279430/
-
Computer molecular docking projection shows the strong potential of nerolidol for inhibiting viral replication and infection
COVID‑19 and therapy with essential oils having antiviral,
anti‑inflammatory, and immunomodulatory properties
Devil's club essential oil (branch bark) has the potential to treat or pretreat for conditions caused by vaccine injury
Vaccine injuries reported announced by the CDC
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/adverse-events.html
and
VAERS database https://vaers.hhs.gov/data.html
Injury: Myocarditis/heart related (55k+)
Preventive effect of nerolidol on isoproterenol induced myocardial damage in Wistar rats: Evidences from biochemical and histopathological studies
https://pubmed.ncbi.nlm.nih.gov/31313346/
"Pretreatment with NRD at different doses (100 and 200 mg/kg b.w) for 21 days prevented the above changes induced by ISO. The 200 mg/kg b.w of NRD was more pronounced than the other dose and brought back all the above parameters near to normalcy."
No medical claims or recommendations are being made here. This is merely a summary of the data published on government websites as it relates to the devil's club EO primary component nerolidol and potential treatments - and the repeating of requests by numerous researchers for clinical trials.
Customer Comments
"15% applied beneath nostrils brought relief to headaches following first and second Moderna vaccines." -April 2021
"I have recommended it a few times to my clients for pain management- topical application. It works great for fibromyaliga, CRPS and nerve pain for post covid patients with myalgia type pain." -February 2022